Mezzion Pharma Co.,Ltd. (KOSDAQ:140410)
41,100
+1,300 (3.27%)
Jun 19, 2025, 3:30 PM KST
Mezzion Pharma Revenue
Mezzion Pharma had revenue of 1.95B KRW in the quarter ending March 31, 2025, a decrease of -9.48%. This brings the company's revenue in the last twelve months to 8.41B, down -67.78% year-over-year. In the year 2024, Mezzion Pharma had annual revenue of 8.61B, down -72.85%.
Revenue (ttm)
8.41B
Revenue Growth
-67.78%
P/S Ratio
146.70
Revenue / Employee
442.48M
Employees
19
Market Cap
1,233.30B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 8.61B | -23.11B | -72.85% |
Dec 31, 2023 | 31.72B | 994.76M | 3.24% |
Dec 31, 2022 | 30.73B | 4.07B | 15.28% |
Dec 31, 2021 | 26.65B | -1.98B | -6.92% |
Dec 31, 2020 | 28.63B | 10.71B | 59.79% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.10T |
SK hynix | 71.40T |
Samsung Biologics | 4,898.69B |
LG Energy Solution | 25.76T |
Hanwha Aerospace | 15.28T |
Hyundai Motor Company | 178.98T |
Kia Corporation | 109.25T |
Doosan Enerbility | 15.88T |